VanEck Associates’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.56M | Sell |
61,246
-357,608
| -85% | -$32.6M | ﹤0.01% | 812 |
|
|
2026
Q1 | $43M | Buy |
418,854
+17,815
| +4% | +$2.01M | 0.03% | 294 |
|
|
2025
Q4 | $50.2M | Buy |
401,039
+24,590
| +7% | +$3.13M | 0.04% | 245 |
|
|
2025
Q3 | $50.4M | Buy |
376,449
+22,977
| +7% | +$3.02M | 0.05% | 222 |
|
|
2025
Q2 | $48.1M | Buy |
353,472
+321,848
| +1,018% | +$42.4M | 0.05% | 210 |
|
|
2025
Q1 | $4.2M | Buy |
31,624
+2,941
| +10% | +$374K | 0.01% | 776 |
|
|
2024
Q4 | $3.24M | Buy |
28,683
+957
| +3% | +$111K | ﹤0.01% | 842 |
|
|
2024
Q3 | $3.24M | Sell |
27,726
-3,458
| -11% | -$379K | ﹤0.01% | 795 |
|
|
2024
Q2 | $3.24M | Buy |
31,184
+1,522
| +5% | +$161K | ﹤0.01% | 729 |
|
|
2024
Q1 | $3.37M | Sell |
29,662
-11,841
| -29% | -$1.36M | 0.01% | 709 |
|
|
2023
Q4 | $4.57M | Sell |
41,503
-229,700
| -85% | -$23M | 0.01% | 569 |
|
|
2023
Q3 | $26.3M | Sell |
271,203
-1,741
| -0.6% | -$183K | 0.06% | 195 |
|
|
2023
Q2 | $29.8M | Buy |
272,944
+12,426
| +5% | +$1.32M | 0.07% | 193 |
|
|
2023
Q1 | $26.4M | Buy |
260,518
+35,707
| +16% | +$3.77M | 0.06% | 205 |
|
|
2022
Q4 | $24.7M | Sell |
224,811
-3,697
| -2% | -$383K | 0.06% | 215 |
|
|
2022
Q3 | $22.1M | Buy |
228,508
+14,456
| +7% | +$1.54M | 0.07% | 208 |
|
|
2022
Q2 | $23.3M | Buy |
214,052
+185,814
| +658% | +$21.1M | 0.06% | 227 |
|
|
2022
Q1 | $3.34M | Buy |
28,238
+462
| +2% | +$57.3K | 0.01% | 596 |
|
|
2021
Q4 | $3.91M | Buy |
27,776
+512
| +2% | +$65.5K | 0.01% | 557 |
|
|
2021
Q3 | $3.22M | Buy |
27,264
+3,138
| +13% | +$385K | 0.01% | 560 |
|
|
2021
Q2 | $2.8M | Sell |
24,126
-89
| -0.4% | -$10.4K | 0.01% | 581 |
|
|
2021
Q1 | $2.9M | Buy |
24,215
+6,007
| +33% | +$712K | 0.01% | 538 |
|
|
2020
Q4 | $1.99M | Buy |
18,208
+106
| +0.6% | +$11.5K | 0.01% | 543 |
|
|
2020
Q3 | $1.97M | Sell |
18,102
-25,012
| -58% | -$2.54M | 0.01% | 491 |
|
|
2020
Q2 | $3.94M | Sell |
43,114
-13,609
| -24% | -$1.23M | 0.01% | 368 |
|
|
2020
Q1 | $4.48M | Sell |
56,723
-13,398
| -19% | -$1.12M | 0.02% | 329 |
|
|
2019
Q4 | $6.09M | Buy |
70,121
+2,696
| +4% | +$226K | 0.02% | 339 |
|
|
2019
Q3 | $5.64M | Buy |
67,425
+2,134
| +3% | +$181K | 0.03% | 319 |
|
|
2019
Q2 | $5.49M | Buy |
65,291
+5,855
| +10% | +$461K | 0.03% | 322 |
|
|
2019
Q1 | $4.75M | Sell |
59,436
-18,524
| -24% | -$1.38M | 0.02% | 321 |
|
|
2018
Q4 | $5.64M | Buy |
77,960
+7,091
| +10% | +$498K | 0.03% | 291 |
|
|
2018
Q3 | $5.2M | Buy |
70,869
+5,446
| +8% | +$358K | 0.03% | 313 |
|
|
2018
Q2 | $3.99M | Buy |
+65,423
| New | +$3.97M | 0.02% | 336 |
|
|
2017
Q1 | – | Sell |
-301,960
| Closed | -$11.6M | – | 884 |
|
|
2016
Q4 | $11.6M | Buy |
301,960
+44,970
| +17% | +$1.78M | 0.06% | 202 |
|
|
2016
Q3 | $10.9M | Sell |
256,990
-48,465
| -16% | -$2.08M | 0.05% | 201 |
|
|
2016
Q2 | $12M | Buy |
305,455
+8,569
| +3% | +$341K | 0.06% | 185 |
|
|
2016
Q1 | $12.4M | Sell |
296,886
-65,894
| -18% | -$2.61M | 0.08% | 158 |
|
|
2015
Q4 | $16.3M | Buy |
362,780
+16,011
| +5% | +$707K | 0.13% | 152 |
|
|
2015
Q3 | $13.9M | Sell |
346,769
-12,863
| -4% | -$606K | 0.11% | 158 |
|
|
2015
Q2 | $17.7M | Buy |
359,632
+42,225
| +13% | +$2.03M | 0.1% | 161 |
|
|
2015
Q1 | $14.7M | Sell |
317,407
-14,510
| -4% | -$666K | 0.08% | 181 |
|
|
2014
Q4 | $14.9M | Sell |
331,917
-89,051
| -21% | -$3.88M | 0.09% | 168 |
|
|
2014
Q3 | $17.5M | Buy |
420,968
+42,083
| +11% | +$1.78M | 0.09% | 158 |
|
|
2014
Q2 | $15.5M | Buy |
378,885
+20,906
| +6% | +$821K | 0.07% | 168 |
|
|
2014
Q1 | $13.8M | Buy |
357,979
+46,534
| +15% | +$1.79M | 0.07% | 171 |
|
|
2013
Q4 | $11.9M | Buy |
311,445
+781
| +0.3% | +$28.8K | 0.06% | 172 |
|
|
2013
Q3 | $10.3M | Buy |
310,664
+13,402
| +5% | +$470K | 0.05% | 172 |
|
|
2013
Q2 | $10.4M | Buy |
+297,262
| New | +$10.9M | 0.06% | 166 |
|
Other funds holding ABT
VanEck Associates's ABT Position: Q2 2026 in Review
VanEck Associates reduced its Abbott (ABT) stake by 85% in Q2 2026, selling an estimated $32.6M and leaving 61,246 shares worth $5.56M. The position accounts for ﹤0.01% of the portfolio, ranked #812.
VanEck Associates first reported a position in ABT in Q2 2013 and has held it in 48 quarters since. The position peaked at $50.4M in Q3 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- VanEck Associates held 61,246 shares of Abbott worth $5.56M as of Q2 2026.
- VanEck Associates sold 357,608 Abbott shares in Q2 2026, an estimated $32.6M.
- Abbott made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #812 holding.
- VanEck Associates first reported a position in Abbott in Q2 2013 and has held it in 48 quarters since.
- VanEck Associates's Abbott position peaked at $50.4M in Q3 2025.
- 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.